125 related articles for article (PubMed ID: 7699233)
21. [Lactitol suppresses the disturbance of consciousness caused by experimentally induced hepatic encephalopathy in rats: an EEG study].
Mushiroi T; Shibahara R; Ukai Y; Hirata Y; Ozaki T; Watanabe M; Kimura K
Nihon Yakurigaku Zasshi; 1995 Feb; 105(2):111-9. PubMed ID: 7737591
[TBL] [Abstract][Full Text] [Related]
22. [Effect of lactitol (NS-4) on the increase in blood and brain ammonia concentration and on coma in newly developed rat models of hepatic coma].
Watanabe M; Ozaki T; Hirata Y; Yoshikuni Y; Kimura K
Nihon Yakurigaku Zasshi; 1995 Feb; 105(2):97-109. PubMed ID: 7737597
[TBL] [Abstract][Full Text] [Related]
23. Lactitol or lactulose in the treatment of chronic hepatic encephalopathy: results of a meta-analysis.
Blanc P; Daures JP; Rouillon JM; Peray P; Pierrugues R; Larrey D; Gremy F; Michel H
Hepatology; 1992 Feb; 15(2):222-8. PubMed ID: 1531204
[TBL] [Abstract][Full Text] [Related]
24. [A clinical comparative study of crystalline pure lactulose and powder pure lactitol in portasystemic encephalopathy of cirrhotic patients].
Grandi M; Sacchetti C; Pederzoli S; Celani MF
Minerva Gastroenterol Dietol; 1991; 37(4):225-30. PubMed ID: 1805974
[TBL] [Abstract][Full Text] [Related]
25. Acidifying enemas (lactitol and lactose) vs. nonacidifying enemas (tap water) to treat acute portal-systemic encephalopathy: a double-blind, randomized clinical trial.
Uribe M; Campollo O; Vargas F; Ravelli GP; Mundo F; Zapata L; Gil S; Garcia-Ramos G
Hepatology; 1987; 7(4):639-43. PubMed ID: 3301614
[TBL] [Abstract][Full Text] [Related]
26. [Ameliorating effect of lactitol on experimental hepatic encephalopathy in Eck fistula dogs].
Watanabe M; Ozaki T; Mushiroi T; Ukai Y; Ueda F; Kimura K; Katoh M; Matsumoto A; Kotani E; Itoh S
Nihon Yakurigaku Zasshi; 1995 May; 105(5):403-13. PubMed ID: 7628788
[TBL] [Abstract][Full Text] [Related]
27. [The effect of lactitol (NS-4) on the concentrations of ammonia and amino acids in blood and cerebrospinal fluid in Eck fistula (portacaval-shunted) dogs].
Watanabe M; Ozaki T; Hirata Y; Yoshikuni Y; Kimura K; Suzuki K; Sato S
Nihon Yakurigaku Zasshi; 1995 May; 105(5):389-402. PubMed ID: 7628787
[TBL] [Abstract][Full Text] [Related]
28. Oral glutamine challenge improves the performance of psychometric tests for the diagnosis of minimal hepatic encephalopathy in patients with liver cirrhosis.
Irimia R; Stanciu C; Cojocariu C; Sfarti C; Trifan A
J Gastrointestin Liver Dis; 2013 Sep; 22(3):277-81. PubMed ID: 24078984
[TBL] [Abstract][Full Text] [Related]
29. Lactitol, a second-generation disaccharide for treatment of chronic portal-systemic encephalopathy. A double-blind, crossover, randomized clinical trial.
Uribe M; Toledo H; Perez F; Vargas F; Gil S; Garcia-Ramos G; Ravelli GP; Guevara L
Dig Dis Sci; 1987 Dec; 32(12):1345-53. PubMed ID: 3319453
[TBL] [Abstract][Full Text] [Related]
30. [Lactitol and neomycin: monotherapy or combined therapy in the prevention and treatment of hepatic encephalopathy?].
Scevola D; Zambelli A; Concia E; Perversi L; Candiani C
Clin Ter; 1989 Apr; 129(2):105-11. PubMed ID: 2525995
[TBL] [Abstract][Full Text] [Related]
31. The effect of lactulose and lactitol administration on fecal fat excretion in patients with liver cirrhosis.
Merli M; Caschera M; Piat C; Pinto G; Diofebi M; Riggio O
J Clin Gastroenterol; 1992 Sep; 15(2):125-7. PubMed ID: 1401823
[TBL] [Abstract][Full Text] [Related]
32. The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis.
Quero JC; Hartmann IJ; Meulstee J; Hop WC; Schalm SW
Hepatology; 1996 Sep; 24(3):556-60. PubMed ID: 8781324
[TBL] [Abstract][Full Text] [Related]
33. Mechanism for lowering blood ammonia levels by lactitol.
Watanabe M; Ozaki T; Hirata Y; Yamamoto O; Niida H; Ueda F; Yoshikuni Y; Kimura K
Jpn J Pharmacol; 1995 Apr; 67(4):369-74. PubMed ID: 7650870
[TBL] [Abstract][Full Text] [Related]
34. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations.
Nolte W; Wiltfang J; Schindler C; Münke H; Unterberg K; Zumhasch U; Figulla HR; Werner G; Hartmann H; Ramadori G
Hepatology; 1998 Nov; 28(5):1215-25. PubMed ID: 9794904
[TBL] [Abstract][Full Text] [Related]
35. Amino acid challenge in patients with cirrhosis: a model for the assessment of treatments for hepatic encephalopathy.
Douglass A; Al Mardini H; Record C
J Hepatol; 2001 May; 34(5):658-64. PubMed ID: 11434611
[TBL] [Abstract][Full Text] [Related]
36. Probiotics prevent hepatic encephalopathy in patients with cirrhosis: a randomized controlled trial.
Lunia MK; Sharma BC; Sharma P; Sachdeva S; Srivastava S
Clin Gastroenterol Hepatol; 2014 Jun; 12(6):1003-8.e1. PubMed ID: 24246768
[TBL] [Abstract][Full Text] [Related]
37. Screening of subclinical hepatic encephalopathy.
Groeneweg M; Moerland W; Quero JC; Hop WC; Krabbe PF; Schalm SW
J Hepatol; 2000 May; 32(5):748-53. PubMed ID: 10845661
[TBL] [Abstract][Full Text] [Related]
38. Comparative modes of action of lactitol and lactulose in the treatment of hepatic encephalopathy.
Patil DH; Westaby D; Mahida YR; Palmer KR; Rees R; Clark ML; Dawson AM; Silk DB
Gut; 1987 Mar; 28(3):255-9. PubMed ID: 3570029
[TBL] [Abstract][Full Text] [Related]
39. Bispectral index monitoring for diagnosis and assessment of severity of hepatic encephalopathy in cirrhotic patients.
Jindal A; Sharma BC; Sachdeva S; Chawla R; Srivastava S; Maharshi S
Dig Liver Dis; 2015 Sep; 47(9):769-74. PubMed ID: 26022229
[TBL] [Abstract][Full Text] [Related]
40. Covert hepatic encephalopathy: agreement and predictive validity of different indices.
Montagnese S; Balistreri E; Schiff S; De Rui M; Angeli P; Zanus G; Cillo U; Bombonato G; Bolognesi M; Sacerdoti D; Gatta A; Merkel C; Amodio P
World J Gastroenterol; 2014 Nov; 20(42):15756-62. PubMed ID: 25400460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
